(Reuters) - Sophiris Bio Inc said interim data showed that its only pipeline compound did not meet a predetermined threshold for efficacy in treating lower urinary tract symptoms of enlarged prostate.
via Reuters: Health News Read More Here..
No comments:
Post a Comment